Document is current

Article History

Accepted: 28 April 2025

First Online: 26 May 2025

Declarations

:

: Open access funding provided by SCELC, Statewide California Electronic Library Consortium.This article was funded by Novartis Pharmaceuticals Corporation. Medical writing and editorial support was provided by Greg Rowe, MSc, and Laura McArdle, BA, of Spark (a division of Prime, New York, NY, USA) and was funded by Novartis Pharmaceuticals Corporation.

: Phillip H. Kuo received honoraria from Attralus, Blue Earth Diagnostics, dGenThera, Eli Lilly, General Electric Healthcare, Invicro, Novartis, and Telix Pharmaceuticals, research grants for his institution from Blue Earth Diagnostics and General Electric Healthcare, consulting fees from Attralus, Blue Earth Diagnostics, Chimerix, dGenThera, Eli Lilly, Fusion Pharma, General Electric Healthcare, Invicro, Life Molecular Imaging, Navidea, Novartis, Radionetics, Telix Pharmaceuticals, and United Imaging, support for attending meetings/travel from Blue Earth Diagnostics, Eli Lilly, General Electric Healthcare, Invicro, Novartis, and Telix Pharmaceuticals, served on an advisory board for dGenThera, has a patent planned/issued/pending (Patent No. US 10,013,743 B2), received equipment/materials/drugs/medical writing services/gifts/other services from Blue Earth Diagnostics, General Electric Healthcare, and Novartis, and holds a leadership/fiduciary role at the Society of Nuclear Medicine and Molecular Imaging and the International Accreditation Council. Jeremie Calais received honoraria from Amgen, Astellas, Bayer, Blue Earth Diagnostics, Curium Pharma, DS Pharma, Fibrogen, GE Healthcare, Isoray, IBA RadioPharma, Janssen Pharmaceuticals, Lightpoint Medical, Lantheus/Progenics/EXINI, Monrol, Novartis/Advanced Accelerator Applications, Pfizer, POINT Biopharma, Radiomedix, Sanofi, Siemens/Varian, SOFIE, and Telix Pharmaceuticals and research grants for his institution from Lantheus/Progenics/EXINI, Novartis/Advanced Accelerator Applications, and POINT Biopharma. Mike Crosby received honoraria from Pfizer and Johnson & Johnson and served on an advisory board/steering committee for Telix Pharmaceuticals, Novartis, and Johnson & Johnson.

: Not applicable.

: Not applicable.

: Not applicable.

: The data supporting the conclusion of this study have been included within the article.

: Not applicable.

: All authors discussed and conceived the idea for this article together. Literature searches and data analyses were performed by Spark, under the direction of Novartis Pharmaceuticals and the authors. All authors contributed to the drafting and critical review of this manuscript, and all authors read and approved the final manuscript.